739 related articles for article (PubMed ID: 26578113)
1. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
Bedada FB; Wheelwright M; Metzger JM
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
[TBL] [Abstract][Full Text] [Related]
2. High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.
Del Álamo JC; Lemons D; Serrano R; Savchenko A; Cerignoli F; Bodmer R; Mercola M
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1717-27. PubMed ID: 26952934
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.
Denning C; Borgdorff V; Crutchley J; Firth KS; George V; Kalra S; Kondrashov A; Hoang MD; Mosqueira D; Patel A; Prodanov L; Rajamohan D; Skarnes WC; Smith JG; Young LE
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1728-48. PubMed ID: 26524115
[TBL] [Abstract][Full Text] [Related]
4. Heart regeneration.
Breckwoldt K; Weinberger F; Eschenhagen T
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1749-59. PubMed ID: 26597703
[TBL] [Abstract][Full Text] [Related]
5. Generation of cardiac pacemaker cells by programming and differentiation.
Husse B; Franz WM
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1948-52. PubMed ID: 26681531
[TBL] [Abstract][Full Text] [Related]
6. Engineering Cardiac Muscle Tissue: A Maturating Field of Research.
Weinberger F; Mannhardt I; Eschenhagen T
Circ Res; 2017 Apr; 120(9):1487-1500. PubMed ID: 28450366
[TBL] [Abstract][Full Text] [Related]
7. 3D culture for cardiac cells.
Zuppinger C
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1873-81. PubMed ID: 26658163
[TBL] [Abstract][Full Text] [Related]
8. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
9. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
10. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.
Dierickx P; Doevendans PA; Geijsen N; van Laake LW
J Cardiovasc Transl Res; 2012 Oct; 5(5):566-80. PubMed ID: 22806916
[TBL] [Abstract][Full Text] [Related]
11. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
[TBL] [Abstract][Full Text] [Related]
12. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
[TBL] [Abstract][Full Text] [Related]
13. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
[TBL] [Abstract][Full Text] [Related]
14. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
[TBL] [Abstract][Full Text] [Related]
15. How to mend a broken heart: adult and induced pluripotent stem cell therapy for heart repair and regeneration.
Wegener M; Bader A; Giri S
Drug Discov Today; 2015 Jun; 20(6):667-85. PubMed ID: 25720353
[TBL] [Abstract][Full Text] [Related]
16. Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.
Ma R; Liang J; Huang W; Guo L; Cai W; Wang L; Paul C; Yang HT; Kim HW; Wang Y
Antioxid Redox Signal; 2018 Feb; 28(5):371-384. PubMed ID: 27903111
[TBL] [Abstract][Full Text] [Related]
17. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
Ye L; Ni X; Zhao ZA; Lei W; Hu S
J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
[TBL] [Abstract][Full Text] [Related]
18. Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function.
Zaunbrecher RJ; Abel AN; Beussman K; Leonard A; von Frieling-Salewsky M; Fields PA; Pabon L; Reinecke H; Yang X; Macadangdang J; Kim DH; Linke WA; Sniadecki NJ; Regnier M; Murry CE
Circulation; 2019 Nov; 140(20):1647-1660. PubMed ID: 31587567
[TBL] [Abstract][Full Text] [Related]
19. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Rampoldi A; Singh M; Wu Q; Duan M; Jha R; Maxwell JT; Bradner JM; Zhang X; Saraf A; Miller GW; Gibson G; Brown LA; Xu C
Toxicol Sci; 2019 May; 169(1):280-292. PubMed ID: 31059573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
